Search Results for: Magnetic resonance imaging apparatus
aflibercept, regorafenib, radium-223 dichloride and riociguat, are intended to contribute to sales growth in the medium term. in the radiology area, we are concentrating on the development of it applications, contrast agents and injection systems for low-radiation computed tomography (ct) and high-field magnetic
resonance imaging (mri) to enable us to offer integrated solutions. our principal research centers are located in berlin, wuppertal and cologne, germany; san francisco and berkeley, united states; turku, finland; and oslo, norway. more information on health care research at bayer 33 million people worldwide...
https://www.bayer.com/en/pharmaceuticals-division.aspx